In the last trading session, 0.1 million shares of the Entero Therapeutics Inc (NASDAQ:ENTO) were traded, and its beta was 0.81. Most recently the company’s share price was $0.38, and it changed around -$0.04 or -8.68% from the last close, which brings the market valuation of the company to $1.81M. ENTO currently trades at a discount to its 52-week high of $2.91, offering almost -665.79% off that amount. The share price’s 52-week low was $0.19, which indicates that the current value has risen by an impressive 50.0% since then.
Entero Therapeutics Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended ENTO as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Entero Therapeutics Inc is expected to report earnings per share of 0 for the current quarter.
Entero Therapeutics Inc (NASDAQ:ENTO) trade information
Instantly ENTO has showed a red trend with a performance of -8.68% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.4888 on recent trading dayincreased the stock’s daily price by 22.26%. The company’s shares are currently down -38.92% year-to-date, but still down -10.46% over the last five days. On the other hand, Entero Therapeutics Inc (NASDAQ:ENTO) is 0.90% up in the 30-day period.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 82.03%.
ENTO Dividends
Entero Therapeutics Inc’s next quarterly earnings report is expected to be released in June.
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 29.91 shares worth $11363.0, making up 0.63% of all outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held roughly 6.65 shares worth around $2525.0, which represents about 0.14% of the total shares outstanding.
